George Eastwood

Board Chair, Interim Executive Director • Emily Whitehead Foundation

Experienced Chief Commercial Officer with a proven track record in the cell and gene therapy industry. Dedicated to addressing challenges in developing and manufacturing cell-based therapeutics, particularly focusing on cGMP materials. Committed to advancing these therapies as a priority, both in my professional role and through my involvement with The Emily Whitehead Foundation.

Also speaking

Jordan Schecter

Vice President, Clinical Development Cellular Therapy Program • Janssen

Vera Araujo

Senior Director, Business Development • Andelyn Biosciences

Amandine Breton

Director MSAT & AST, Cell & Gene Therapies • Orchard Therapeutics

Event Info


Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.


Find out more about partnering at Advanced Therapies Europe.